A rare pulmonary hamartoma: fibroleiomyomatous hamartoma
© The Author(s). 2016
Received: 22 November 2015
Accepted: 31 May 2016
Published: 2 June 2016
Pulmonary hamartomas are more common than expected because they are usually asymptomatic and are either discovered on routine chest radiography or when they are noted incidentally in approximately 0.25 % of autopsies. In contrast, pulmonary fibroleiomyomatous hamartoma, which consists of interlacing bundles of smooth muscle cells admixed with fibrous tissue and numerous tubular or cleft-like epithelial inclusions, is a rare type of hamartoma. Controversy exists regarding the pathogenesis of this tumor. We herein present a rare case of a 68-year-old male patient without a pre-existing smooth muscle tumor, who underwent resection for a tumor that was considered to be a true pulmonary fibroleiomyomatous hamartoma.
Hamartomas are a relatively common form of benign lung tumor. Fibroleiomyomatous hamartomas, on the other hand, are rare. Pulmonary fibroleiomyomatous hamartoma was first described as “diffuse fibroleiomyomatous hamartomatosis” by Cruickshank et al. in 1953 . To date, only five cases of solitary pulmonary fibroleiomyomatous hamartoma have been reported [2, 3]. These tumors represent an important group of benign pulmonary tumors which classically present as incidental “coin lesions” and which must be differentiated from primary and metastatic malignant neoplasms. We herein present a rare case of a patient with a solitary pulmonary fibroleiomyomatous hamartoma.
Single or numerous focal proliferations of the smooth muscle tissue
Tuberous sclerosis with pulmonary changes
According to Spencer, very rare focal changes occur in the walls of the pulmonary alveoli, in the pleural region, and in the walls of the small bronchi. In our case, the bronchial epithelium extended into the alveolar septa in the pulmonary parenchyma without a cartilaginous or adipose element. Spencer suggested that they mainly developed subpleurally and extended towards the hilum. In our case, they reached the subpleural space. Patients with the lesions are generally asymptomatic. Multiple lesions occur more frequently than solitary lesions, and the tumors are more prevalent in women. There are many reports on uterine leiomyomas metastasizing to the lungs .
The histological characteristics of what is currently referred to as fibroleiomyomatous hamartoma or benign metastasizing leiomyoma are as follows: (i) a well-circumscribed nodule composed of smooth muscle cells with numerous epithelial inclusions and (ii) no cellular atypia or mitotic figures [6, 7]. In our case, the proliferation of smooth muscle cells, which were positive for smooth muscle markers such as alpha-SMA, and the extension of bronchial epithelium into the alveolar septa were observed. Neither cellular atypia nor mitotic figures were present. There are several theories on the pathogenesis of this tumor, including (i) that it occurs as a metastasis from a benign leiomyoma or low-grade leiomyosarcoma (most often from the uterus); (ii) that it occurs due to the implantation and proliferation of benign smooth muscle tissue, which is embolized by intravenous leiomyomatosis or by mechanical means; and (iii) that they represent true fibroleiomyomatous hamartoma, originating from the lung. These tumors are not histologically distinguishable. Ito et al. reported that the terms fibroleiomyomatous hamartoma or benign metastasizing leiomyoma could include some cases of low-grade leiomyosarcomas, true benign metastasizing leiomyoma, and true fibroleiomyoma . Since controversy exists about the pathogenesis of this tumor, it was thought that the current diagnostic terms of fibroleiomyomatous hamartoma or benign metastasizing leiomyoma should be reconsidered to avoid misleading diagnoses. In the present cases, the lesion was solitary and occurred in a male who had no history of smooth muscle neoplasm. Thus, true fibroleiomyomatous hamartoma was considered to be the most suitable the diagnostic term to describe the patient’s condition.
Four partial resections and one lobectomy are reported to have been performed in the five reported cases of pulmonary fibroleiomyomatous hamartoma. There are no reports of the postoperative recurrence of pulmonary fibroleiomyomatous hamartoma [2, 3]. We thought preoperative examinations were atypical as a malignant tumor but could not deny malignancy. Therefore, we proposed to initially perform a partial resection for this peripheral lung tumor. It was thought that lobectomy should be performed, only when frozen section had a possibility of malignancy. Surgical intervention is important, not only for achieving a cure but also as a diagnostic measure to rule out malignancy. Complete resection alone seems to be a suitable surgical treatment.
We herein presented a rare resected case of a solitary pulmonary fibroleiomyomatous hamartoma and discussed its differential diagnosis and histogenesis.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
CT, computed tomography; SMA, smooth muscle actin; VATS, video-assisted thoracoscopic surgery
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
- Cruickshank DB, Harrison GK. Diffuse fibro-leiomyomatous hamartomatosis of the lung. Thorax. 1953;8:316–8.View ArticlePubMedPubMed CentralGoogle Scholar
- Okudera K, Umeda S, Otara M, Honda E, Ohmori E, Tajari M, et al. A case of pulmonary hamartoma with distinctive histopathological features: a discussion of its differential diagnosis and histogenesis. Pathol Int. 2014;64:618–23.Google Scholar
- Hassani SN, Nuda R, Bard RL. Fibroleiomyomatous hamartoma of the lung. Respiration. 1979;37:238–40.View ArticlePubMedGoogle Scholar
- Spencer H. Pathology of the lung. Oxford, New York, Toronto, Sydney, Paris, Frankfurt: Pergamon Press; 1977. p. 981–8.Google Scholar
- Itoh H, Yanagi M, Setoyama T, Shirao K, Yanagi S, Kataoka H, et al. Solitary fibroleiomyomatous hamartoma of the lung in a patient without a pre-existing smooth-muscle tumor. Pathol Int. 2001;51:661–5.View ArticlePubMedGoogle Scholar
- Colby VC, Koss MN, Travis WD. Tumors of lower respiratory tract. In: Rosai J, Sobin LH, editors. Atlas of tumor pathology, fascicle 13. Bethesda.: Armed Forces Institute of Pathology; 1995. p. 353–60.Google Scholar
- Carter D, Patchefsky AS. Tumors and tumor-like lesions of the lung. In: LiVolsi VA, editor. Major problem in pathology, fascicle 36. Philadelphia: WB Saunders; 1998. p. 339–47.Google Scholar